retatrutide clinical trial phase Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Phase 2 Trial

If you know that dose-escalation weeks hit you hard, timing the injection for evening means you wake up the next morning past the worst of it

Once you answer the few questions, click the get my plan button to fill out the intake form, which includes some brief notes about medical history (like what medications and supplements you take, how often you enjoy an adult beverage, etc.)

Rather than running separate pivotal trials for each indication, Lilly built a basket-trial structure that evaluates retatrutide in obesity alongside two of its common complications: obstructive sleep apnoea (OSA) and knee osteoarthritis

Available from: Peterli R, Wlnerhanssen BK, Peters T, et al

Additionally, the magnitude of clinical effects differs substantially

For most GLP-1 users, standing head rushes are the most common form of dizziness and dissipate after a few moments